Biomet Press Release

Biomet, Inc. (NASDAQ:BMET) confirmed today that Morgan
Stanley & Co. Incorporated is assisting it in exploring strategic
alternatives focused on enhancing shareholder value. The Company
stated that no decisions have been made and there is no assurance that
this exploration will result in any specific action. Daniel P. Hann,
interim President and Chief Executive Officer, said, "We believe that
this review is a prudent exercise and is consistent with management's
commitment to our shareholders and Team Members."
   The Company also stated that it does not expect to disclose
developments with respect to its exploration of alternatives unless
required.
   Biomet, Inc. and its subsidiaries design, manufacture and market
products used primarily by musculoskeletal medical specialists in both
surgical and non-surgical therapy. The Company's product portfolio
encompasses reconstructive products, including orthopedic joint
replacement devices, bone cements and accessories, and dental
reconstructive implants; fixation products, including electrical bone
growth stimulators, internal and external orthopedic fixation devices,
craniomaxillofacial implants and bone substitute materials; spinal
products, including spinal stimulation devices, spinal hardware and
orthobiologics; and other products, such as arthroscopy products and
softgoods and bracing products. Headquartered in Warsaw, Indiana,
Biomet and its subsidiaries currently distribute products in more than
100 countries.
   For further information contact Greg W. Sasso, Vice President,
Corporate Development and Communications at [phone] or Barbara
Goslee, Manager, Corporate Communications at [phone].
   This press release contains certain statements that are
"forward-looking statements" within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange Act
of 1934, as amended. Although the Company believes that the
assumptions, on which the forward-looking statements contained herein
are based, are reasonable, any of those assumptions could prove to be
inaccurate given the inherent uncertainties as to the occurrence or
non-occurrence of future events. There can be no assurance that the
forward-looking statements contained in this press release will prove
to be accurate. The inclusion of a forward-looking statement herein
should not be regarded as a representation by the Company that the
Company's objectives will be achieved.
   All of Biomet's financial information may be obtained on our
website at www.biomet.com or you may contact us by e-mail at
[e-mail].